3Baron J C, von Kummer R, del Zoppo G J. Treatment of a- cute ischemic stroke. Challenging the concept of a rigid and universal time window[J]. Stroke, 2004, 26(12) : 2219.
4Treib J, Grauer MT, Woessner R, et al. Treatment of stroke on an intensive stroke unit: a novel concept [ J ]. Intensive- Care Med, 2002, 26: 1598-1611.
5Booth RP. Endovascular intervention in acute stroke and oc- clusive vascular disease [ J ]. Jacksonvile Medicine, 2006, 495 -496.
6The National Institute of Neurological Disorders and Stroke rt -PA Stroke Group. Tissue plasminogen activator for acute ische mic stroke[ J]. N Engl Med, 2005, 333: 1581-1587.
7Adams HP, Adams RJ, Brott T, et al. Guidelines for the early management of patients with isehemic stroke: a scien- tific statement from the Stroke Council of the American Stroke As sonciation[ J]. Stroke, 2003, 34: 1056-1083.
8Executive Committee of the ASITN. Intraartefial Thrombolys- is:Ready for prime Time[J]. AJR, 2001,22: 55.
9LISBOA RC, JOVANOVIE BD, ALBERTS MJ. Analysis of the safety and efficacy of imra-arterial thrombolytie ther- apy in ischemic stroke [ J ]. Stroke, 2002, 33 : 2866 - 2871.
10AlbersGW, BatesVE, ClarkWM. Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Aheplase to Reverse Stroke (STARS) study[J].JAMA, 2000,283(9): 1145-1150.
